Single-use Bioprocess Tubing And Assemblies Market (2026 - 2033) Siz

Single-use Bioprocess Tubing And Assemblies Market Summary

The global single-use bioprocess tubing and assemblies market size was valued at USD 3.9 billion in 2025 and is projected to grow from USD 4.5 billion in 2026 to USD 12.5 billion by 2033, at a CAGR of 15.7% from 2026 to 2033. The market in North America dominated with a revenue share of 46.1% in 2025. This growth is driven by the expansion of continuous and integrated bioprocessing workflows, increasing biopharmaceutical R&D, and the expansion of vaccine and rapid response biomanufacturing capacity.

Market Dynamics

Market Characteristics

The single-use bioprocess tubing & assemblies market is characterized by continuous innovation focused on sterility assurance, contamination prevention, and process efficiency. Manufacturers are developing advanced tubing materials, pre-sterilized assemblies, and integrated fluid transfer systems to support high-performance biopharmaceutical manufacturing. Innovations are also targeting improved compatibility with cell & gene therapy workflows, vaccine manufacturing, and automated bioprocessing systems. Companies are integrating gamma-sterilized and cleanroom-manufactured assemblies to reduce validation requirements and minimize operational risks. For instance, in April 2026, Freudenberg Medical launched CleanAssure, an ISO Class 5 controlled cleanroom designed to provide washed, dried, and gamma-sterilized single-use assemblies for biopharmaceutical applications. The facility enhances sterility, reduces contamination risks, and supports process consistency for applications such as vaccine production, cell cultivation, fluid transfer, and fill-finish operation.

“CleanAssure allows us to support our customers beyond component manufacturing, by integrating controlled cleaning and sterilization into our single-use assembly services, we help reduce contamination risk, streamline validation activities, and support a reliable supply for our customers. We can now support customers with their entire component value chain and allow them to focus on their core manufacturing capability.”

Rudi Gall, VP, Global Pharma, Freudenberg Medical.

The market demonstrates a high level of collaboration among bioprocess solution providers, biopharmaceutical manufacturers, and contract development organizations. Strategic partnerships are increasingly being formed to improve supply chain reliability, accelerate product customization, and expand single-use technology integration across manufacturing facilities. Collaborations also support co-development of specialized tubing assemblies for complex biologics and cell therapy production processes. Companies are partnering with automation and fluid management providers to enhance workflow integration and process scalability. These partnerships help manufacturers address evolving regulatory requirements while improving operational flexibility and manufacturing efficiency. For instance, in September 2023, Repligen Corporation announced the acquisition of Metenova AB to strengthen its fluid management and single-use bioprocessing portfolio.

Regulatory compliance plays a critical role in the single-use bioprocess tubing & assemblies market due to the stringent quality and sterility requirements associated with biopharmaceutical production. Regulatory agencies emphasize contamination control, extractables and leachables testing, material traceability, and validation of sterilization processes. Manufacturers are increasingly adopting ISO-certified cleanroom environments and gamma sterilization standards to comply with global bioprocessing regulations. The growing use of single-use systems in commercial biologics manufacturing has also increased the need for standardized documentation and quality assurance procedures. Compliance with FDA, EMA, and GMP regulations continues to influence product design, material selection, and manufacturing practices across the industry

Companies operating in the market are actively expanding their product portfolios to offer comprehensive fluid management and single-use bioprocessing solutions. Product expansion strategies focus on integrating tubing, connectors, pumps, mixers, and customized assemblies into unified platforms that support end-to-end manufacturing workflows. Manufacturers are also introducing application-specific assemblies for upstream processing, fill-finish operations, and cell therapy manufacturing. Increasing demand for scalable and modular systems is driving the development of engineered-to-order solutions compatible with both pilot-scale and commercial production environments. These expansions enable suppliers to improve process integration, operational flexibility, and customer-specific customization capabilities. For instance, in April 2026, Avantor Inc. expanded and unified its Masterflex fluid management portfolio, adding peristaltic pumps, tubing, single-use assemblies, mixers, and engineered-to-order fluid-handling systems for bioprocess manufacturing. The expanded portfolio is designed to improve secure fluid transfer, process scalability, and integration across R&D, pilot-scale, and commercial biopharmaceutical production workflows.

Regional expansion activities in the single-use bioprocess tubing & assemblies market are increasing as manufacturers seek to strengthen supply chain resilience and support growing biologics production capacity worldwide. Companies are expanding manufacturing facilities, cleanroom operations, and distribution networks across North America, Europe, and Asia Pacific to address rising demand from biopharmaceutical and cell therapy sectors. Asia Pacific is emerging as a major investment destination due to expanding biologics manufacturing infrastructure and increasing outsourcing activities. Regional expansion also helps suppliers improve lead times, reduce logistics complexity, and ensure localized technical support for customers. Additionally, companies are investing in strategically located production facilities to enhance business continuity and meet regional regulatory standards.

Case Study: Standardized Single Use Assemblies Supporting Flexible Biopharmaceutical Manufacturing

Background

The rapid adoption of single-use technologies (SUTs) in biopharmaceutical manufacturing has increased the demand for flexible, scalable, and contamination-free production systems. However, highly customized single-use assemblies often create interoperability limitations, supply chain dependencies, and operational inefficiencies.

To address these challenges, biopharmaceutical manufacturers increasingly adopted standardized modular single-use tubing assemblies and aseptic connector systems to simplify integration across multiple processing platforms.

Challenge

Manufacturers using customized single-use systems faced several operational challenges, including:

• Vendor lock-in due to proprietary consumables and connectors

• Limited compatibility between different supplier systems

• Long procurement lead times for custom assemblies

• Supply chain disruptions and inventory redundancies

• Difficulty scaling processes across multi-product facilities

These issues increased manufacturing complexity, operational costs, and risks related to production continuity.

Solution

Industry experts promoted the use of standardized modular single-use assemblies consisting of interchangeable tubing and connector components that could be configured for multiple bioprocessing applications.

The modular approach included components such as:

• Wye, tee, and cross tubing assemblies

• Inline filter assemblies

• Sample assemblies

• Tubing jumpers and manifolds

• Aseptic sterile connectors and tubing welders

These standardized assemblies enabled plug-and-play integration across upstream and downstream operations while supporting fully closed aseptic processing systems. The approach also allowed manufacturers to create scalable configurations for batch, fed batch, and continuous bioprocessing applications.

Outcomes

• Improved process flexibility and scalability across facilities

• Reduced vendor lock-in and enhanced supply chain resilience

• Faster assembly integration and simplified operator training

• Lower inventory redundancies and reduced procurement complexity

• Improved aseptic processing and contamination control

The case highlights the growing importance of standardized single-use tubing assemblies and modular fluid management systems in the global single-use bioprocess tubing & assemblies market, particularly for biologics, vaccine, and cell & gene therapy manufacturing.

Product Insights

The fluid transfer assemblies segment held the largest market share of 38.5% in 2025. This assembly play the significant role in the sterile transfer of media, buffers, process fluids, and biologic products across biopharmaceutical manufacturing operations. These assemblies typically integrate tubing, connectors, manifolds, clamps, filters, and bags into ready-to-use fluid management systems that support contamination-free and closed-system processing environments. Fluid transfer assemblies are widely utilized in upstream processing, downstream purification, sampling, and fill-finish applications.

The standalone bioprocess tubing segment is expected to grow at the fastest CAGR of 17.7% over the forecast period. This is due to widely used for sterile fluid transfer, media handling, buffer transfer, sampling, filtration, and fill-finish operations across biopharmaceutical manufacturing facilities. The standalone bioprocess tubing segment includes silicone tubing, thermoplastic elastomer (TPE) tubing, peristaltic pump tubing, and high-purity transfer tubing used across upstream and downstream bioprocessing workflows. These tubing systems support closed-system processing while reducing contamination risks, cleaning validation requirements, and operational downtime associated with conventional stainless-steel systems. Rising production of biologics, vaccines, biosimilars, and cell & gene therapies is significantly driving demand for high-performance disposable tubing solutions.

Application Insights

The fluid transfer segment held the largest market share of 43.3% in 2025. This dominance is due to the extensive requirement for sterile movement of media, buffers, biologics, and process fluids across biopharmaceutical manufacturing operations. These systems are widely utilized in upstream processing, downstream purification, and fill-finish workflows to maintain contamination-free fluid handling while reducing cleaning validation and operational downtime.

The cell culture & mixing segment is expected to grow at the fastest CAGR of 17.1% during the forecast period from 2026 to 2033 in the single-use bioprocess tubing & assemblies market. Cell culture and mixing operations extensively rely on single-use tubing & assemblies for the sterile transfer of media, nutrients, gases, and buffers between bioreactors, mixing systems, and storage containers. These systems play a critical role in maintaining closed, contamination-free manufacturing environments across biologics, vaccine, and advanced therapy production workflows. The increasing adoption of single-use bioprocessing technologies to improve operational flexibility, reduce cross-contamination risks, and support scalable manufacturing is further driving segment growth.

Solution Insights

The customized solutions segment dominated the market in 2025, and is expected to grow at the fastest CAGR over the forecast period.  This is due to the increasing demand for application-specific fluid management systems across biologics, vaccines, and cell & gene therapy manufacturing. The customized solutions are specifically designed to meet unique bioprocessing requirements, including flow configuration, tubing length, connector integration, filtration setup, manifold design, and equipment compatibility. Customized assemblies help manufacturers improve process flexibility, reduce manual intervention, and support closed-system processing environments.

The standard solutions segment is expected to grow at a significant CAGR over the forecast period, due to their broad utilization in routine fluid transfer, media handling, sampling, and filtration operations across biopharmaceutical manufacturing facilities. These pre-configured systems typically include standardized tubing assemblies, manifolds, connectors, clamps, and transfer components designed to simplify installation and support consistent manufacturing operations.

End Use Insights

Biopharmaceutical and pharmaceutical companies dominated the market, accounting for 54.2% of revenue in 2025. This dominance is driven by the widespread adoption of disposable fluid management systems in biologics, vaccines, biosimilars, and injectable drug manufacturing. These companies use single-use tubing and assembly systems for sterile fluid transfer, media handling, sampling, storage, and fill-finish applications to improve manufacturing flexibility and reduce contamination risks. The growth of closed-system manufacturing and modular production facilities is driving demand for high-purity tubing assemblies and integrated fluid transfer systems. Manufacturers adopt disposable technologies to reduce cleaning validation, minimize downtime, and improve production turnaround times in commercial facilities.

In addition, growing investments in biologics manufacturing capacity are further supporting market growth. For instance, in April 2024, FUJIFILM invested an additional USD1.2 billion in its North Carolina biologics facility, increasing total investment to over USD 3.2 billion and adding eight 20,000-liter bioreactors for large-scale biologics production.

The Cell & gene therapy developers’ segment is anticipated to register the fastest CAGR over the forecast period from 2026 to 2033. The increasing commercialization of advanced therapies is driving demand for highly sterile and closed-system manufacturing environments. Cell & gene therapy developers extensively use single-use tubing assemblies, cryogenic-compatible transfer systems, and sterile fluid-handling technologies for cell processing, media transfer, formulation, and final fill applications.

In addition, the complexity and sensitivity of cell & gene therapy workflows are significantly driving demand for low hold-up volume tubing, sterile connectors, and customized transfer assemblies designed to minimize contamination risks and maintain product integrity. Key players are focusing on cryogenic-compatible materials, reconnectable systems, and automation-ready tubing assemblies to support evolving advanced therapy manufacturing workflows.

Regional Insights

North America dominated the single-use bioprocess tubing & assemblies market, accounting for 46.1% of revenue in 2025. The regional market growth is driven by the strong presence of biopharmaceutical manufacturers, increasing biologics production, and the widespread adoption of single-use technologies across upstream and downstream bioprocessing operations. The growing demand for contamination-free fluid management systems, the expansion of cell & gene therapy manufacturing, and rising investments in biomanufacturing infrastructure further support market growth. In addition, technological advancements in sterile tubing assemblies, integrated fluid-transfer systems, and customized single-use solutions are driving increased adoption across commercial-scale manufacturing facilities.

U.S. Single-use Bioprocess Tubing & Assemblies Market Trends

Single-use bioprocess tubing & assemblies market in the U.S. is dominated by the region due to the presence of large-scale biopharmaceutical manufacturing facilities and advanced biologics production capabilities. The country continues to see strong investment in monoclonal antibodies, vaccines, and cell & gene therapies, which require highly efficient, sterile fluid-transfer systems. Increasing adoption of single-use assemblies to improve manufacturing flexibility, reduce cross-contamination risks, and optimize operational efficiency is further driving market growth. In addition, growing investments in bioprocess automation and continuous manufacturing technologies are accelerating the demand for customized tubing assemblies and integrated fluid management systems.

Europe Single-use Bioprocess Tubing & Assemblies Market Trends

Europe represents a significant market for single-use bioprocess tubing & assemblies due to the strong presence of established biopharmaceutical companies and advanced manufacturing infrastructure. Countries such as Germany, the UK, Switzerland, France, and Italy are actively investing in biologics manufacturing and advanced therapy production facilities. The increasing adoption of single-use systems to support flexible, scalable manufacturing operations is driving market growth across the region. Furthermore, stringent regulatory standards regarding sterility assurance, contamination control, and process validation are encouraging manufacturers to adopt high-quality single-use tubing and assembly solutions.

The market for single-use bioprocess tubing & assemblies in UK is growing due to an increasing government support for life sciences and domestic biomanufacturing expansion drives regional market growth. Investments in advanced therapy manufacturing centers, biologics production, and cell & gene therapy research are driving the demand for sterile and customizable fluid transfer systems. In addition, collaborations between research institutes, biotechnology companies, and contract manufacturing organizations are supporting the development and commercialization of advanced single-use technologies. The growing focus on reducing operational complexity and improving process efficiency is also accelerating the adoption of tubing assemblies and fluid handling systems across the country.

Germany single-use bioprocess tubing & assemblies market is experiencing significant growth in the single-use bioprocess tubing & assemblies market, driven by the strong presence of biotechnology companies, biopharmaceutical manufacturers, and engineering-driven process innovation. The country’s advanced manufacturing capabilities and increasing investments in biologics and biosimilar production are driving demand for high-performance fluid-transfer and sterile-tubing systems. In addition, contract development and manufacturing organizations (CDMOs) are expanding their single-use bioprocessing capacity to support growing outsourcing activities. The growing focus on automation and process optimization is further driving the adoption of integrated tubing and assembly solutions in Germany.

Asia Pacific Single-use Bioprocess Tubing & Assemblies Market Trends

Asia Pacific is anticipated to grow at the fastest over the forecast period from 2026 to 2033. This is driven by expanding biopharmaceutical manufacturing activities in China, India, South Korea, and Japan. Factors such as improving healthcare infrastructure, increasing investments in biotechnology, and rising adoption of biologics are supporting market expansion. The growing presence of contract manufacturing organizations and the increasing outsourcing of bioprocessing activities are also driving demand for single-use tubing assemblies and fluid transfer systems. Moreover, global manufacturers are expanding their regional presence to strengthen supply chains and support increasing production requirements in emerging Asian markets.

The China single-use bioprocess tubing & assemblies market is growing significantly due to increasing investments in domestic biopharmaceutical manufacturing and rising demand for biologics and biosimilars. Government initiatives supporting biotechnology innovation and local manufacturing capabilities are accelerating the adoption of advanced bioprocessing technologies. In addition, international companies are expanding partnerships and manufacturing operations in China to strengthen regional supply chains and improve market access. The rapid expansion of biologics production facilities and increasing demand for contamination-free manufacturing processes are further driving the adoption of single-use tubing systems and customized fluid transfer assemblies across the country.

Latin America Single-use Bioprocess Tubing & Assemblies Market Trends

The Latin America single-use bioprocess tubing & assemblies market is experiencing steady growth due to the expansion of the biotechnology and biopharmaceutical sectors in countries such as Brazil, Mexico, and Argentina. Increasing healthcare investments and rising demand for biologics and biosimilars are supporting the adoption of flexible and cost-effective bioprocessing technologies. Single-use tubing assemblies are gaining traction as manufacturers seek to reduce cleaning requirements, lower operational costs, and improve production efficiency. However, dependence on imported technologies and limited local manufacturing infrastructure may moderately restrain market growth across the region.

Middle East & Africa Single-use Bioprocess Tubing & Assemblies Market Trends

The Middle East & Africa single-use bioprocess tubing & assemblies market is expected to significantly during the forecast period. Growth is driven by increasing investments in pharmaceutical manufacturing, expanding healthcare infrastructure, and the gradual development of biotechnology capabilities across the region. Countries such as the UAE and Saudi Arabia are investing in advanced healthcare and life sciences infrastructure to strengthen domestic pharmaceutical production. South Africa also represents a key market due to its relatively developed healthcare and research ecosystem. However, limited skilled workforce availability and lower R&D expenditure in several countries may continue to challenge market expansion in the region.

Key Single-use Bioprocess Tubing & Assemblies Company Insights

The market players operating in the single-use bioprocess tubing & assemblies market are adopting product approval to increase the reach of their products in the market, improve their availability in diverse geographical areas, and expand to enhance production/research activities. This strategy enables companies to increase their capabilities, expand their product portfolios, and improve their competencies.

Key Single-use Bioprocess Tubing & Assemblies Companies

The following key companies have been profiled for this study on the single-use bioprocess tubing & assemblies market

• Thermo Fisher Scientific Inc.

• Merck KGaA

• Sartorius AG

• Danaher Corporation

• Avantor Inc.

• Saint-Gobain Life Sciences

• Entegris Inc.

• Foxx Life Sciences

• Eldon James

• Repligen Corporation

• Parker Hannifin Corp

• Corning Incorporated

• Watson-Marlow Fluid Technology Solutions (Spirax Group plc)

• Kuhner AG

Competitive Benchmarking

Recent Development

• In April 2026, Feudenberg Medical launched CleanAssure, an ISO Class 5 controlled cleanroom designed to provide washed, dried, and gamma-sterilized single-use assemblies for biopharmaceutical applications. The facility enhances sterility, reduces contamination risks, and supports process consistency for applications such as vaccine production, cell cultivation, fluid transfer, and fill-finish operation.

“CleanAssure allows us to support our customers beyond component manufacturing, by integrating controlled cleaning and sterilization into our single-use assembly services, we help reduce contamination risk, streamline validation activities, and support a reliable supply for our customers. We can now support customers with their entire component value chain and allow them to focus on their core manufacturing capability.”

- Rudi Gall, vp, global pharma, Freudenberg Medical.

• In February 2025, Saint-Gobain Life Sciences introduced C-Flex Advance Bio tubing designed for weldable sterile fluid transfer applications in single-use biopharmaceutical manufacturing.

Single-use Bioprocess Tubing And Assemblies Market